Literature DB >> 12510707

Pharmacy assistance programs in a community health center setting.

Maxsimo C Torres1, Debra Herman, Seferino Montano, Leah Love.   

Abstract

Prescription drug costs represent the fastest growing item in health care and are a driving force in rapidly increasing health care costs. Community health centers serve an indigent population with limited access to pharmaceuticals. Pharmaceutical companies sponsor patient assistance programs. These pharmacy assistance programs can be developed to facilitate the provision of needed pharmaceuticals to this vulnerable population. La Casa de Buena Salud is a rural community health center in eastern New Mexico, which has provided access to a substantial amount of pharmaceuticals to indigent patients through patient assistance programs. Cost savings potential are considerable for a community health center and for patients when a pharmacy assistance program is organized efficiently and employed systematically. Secondary benefits are derived from the entire medical community. While some community health centers currently make effective use of pharmaceutical company-sponsored pharmacy assistance programs, a comprehensive, long-term approach at a national level may be required.

Entities:  

Mesh:

Year:  2002        PMID: 12510707      PMCID: PMC2568413     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  8 in total

1.  Pharmaceutical manufacturer assistance programs for indigent patients: solution or symptom?

Authors:  L R Van Diepen
Journal:  Am J Health Syst Pharm       Date:  2001-01-15       Impact factor: 2.637

2.  The prescription-drug problem.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

3.  Medicaid managed care and coverage of prescription medications.

Authors:  Robert J Buchanan
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

4.  Medication nonadherence and its relation to financial restriction.

Authors:  W Paris; S Dunham; A Sebastian; C Jacobs; B Nour
Journal:  J Transpl Coord       Date:  1999-09

5.  Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program.

Authors:  S Weiner; J Dischler; C Horvitz
Journal:  Am J Health Syst Pharm       Date:  2001-01-15       Impact factor: 2.637

6.  Impact of an indigent care program on use of resources: experiences at one hospital.

Authors:  D Nykamp; D Ruggles
Journal:  Pharmacotherapy       Date:  2000-02       Impact factor: 4.705

7.  Medication assistance programs for uninsured and indigent patients.

Authors:  M A Chisholm; B O Reinhardt; L J Vollenweider; B D Kendrick; J T DiPiro
Journal:  Am J Health Syst Pharm       Date:  2000-06-15       Impact factor: 2.637

8.  Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Authors:  Sebastian Schneeweiss; Alexander M Walker; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Stephen B Soumerai
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.